Exact Sciences
EXAS
#1543
Rank
NZ$19.42 B
Marketcap
$104.95
Share price
5.86%
Change (1 day)
-10.13%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.80. In 2022 the company made an earnings per share (EPS) of -$6.25 a decrease over its 2021 EPS that were of -$6.11.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.54-59.42%
2022-$6.252.31%
2021-$6.11-37.09%
2020-$9.72674.65%
2019-$1.25-50.69%
2018-$2.5444%
2017-$1.77-39.39%
2016-$2.92-2.94%
2015-$3.0037.1%
2014-$2.1979.71%
2013-$1.22-21.59%
2012-$1.5562.96%
2011-$0.9592.86%
2010-$0.49-3.45%
2009-$0.51-19.44%
2008-$0.64-18.18%
2007-$0.78-10.2%
2006-$0.87-10.91%
2005-$0.97-24.66%
2004-$1.29-51.33%
2003-$2.65-7.41%
2002-$2.8611.72%
2001-$2.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.37 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.60-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.71-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$89.93 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.62-300.57%๐Ÿ‡ซ๐Ÿ‡ท France